Nivolumab induced radiation recall pneumonitis after two years of radiotherapy

Ann Oncol. 2017 Jun 1;28(6):1404-1405. doi: 10.1093/annonc/mdx115.

Authors

R Shibaki¹, H Akamatsu¹, M Fujimoto², Y Koh¹, N Yamamoto¹

Affiliations

¹ Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
² Department of Diagnostic Pathology, Wakayama Medical University, Wakayama City, Wakayama, Japan.

PMID: 28383674
DOI: 10.1093/annonc/mdx115

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects*
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / radiotherapy
Male
Neoplasms, Squamous Cell / drug therapy
Neoplasms, Squamous Cell / radiotherapy
Nivolumab
Radiation Pneumonitis / chemically induced
Radiation Pneumonitis / etiology*

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Nivolumab